NASDAQ · Drug Manufacturers - Specialty & Generic

Collegium Pharmaceutical, Inc. (COLL) Stock

$22.30 +0.86% NASDAQ: COLL Healthcare

Valuation

MetricValue
Price$22.30
Market Cap$723.27M
P/E Ratio14.47
P/B Ratio2.30
P/S Ratio0.89
EPS (TTM)$0.00
52-Week High$50.79
52-Week Low$21.58
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE15.96%
ROA2.24%
ROCE10.25%
Gross Margin89.17%
Operating Margin15.96%
Net Margin5.93%
Debt/Equity2.75
Current Ratio1.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$277.0M$464.0M$567.0M$631.0M$781.0M
Operating Profit$18.0M$33.0M$167.0M$170.0M$187.0M
Net Profit$72.0M$-25.0M$48.0M$69.0M$63.0M
EPS$1.86$-0.74$1.29$1.86$1.73
Op Margin6.4%7.2%29.5%26.9%24.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$692.0M$1.2B$1.1B$1.7B$1.7B
Total Liabilities$489.0M$979.0M$948.0M$1.4B$1.4B
Cash$186.0M$174.0M$239.0M$71.0M$251.0M
Borrowings$259.0M$709.0M$674.0M$859.0M$941.0M

Latest News

COLL: Lowering target price to $33.00 Argus Research · Jul 15, 2026 Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? Zacks · Jul 9, 2026 4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues Zacks · Jul 8, 2026 1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm StockStory · Jul 7, 2026 1 Mooning Stock to Own for Decades and 2 That Underwhelm StockStory · Jul 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$104.0M$124.0M$275.0M$205.0M$329.0M
Investing Cash Flow$-4.0M$-575.0M$-71.0M$-289.0M$-65.0M
Financing Cash Flow$-39.0M$-6.0M$-74.0M$-68.0M$-46.0M
Net Cash Flow$12.0M$-13.0M$64.0M$-143.0M$156.0M
Free Cash Flow$102.0M$123.0M$274.0M$203.0M$328.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.49
EV / EBITDA2.47
FCF Yield45.71%
Quick Ratio0.84
Interest Coverage0.98
Return 1Y9.81%
Return 3Y57.48%
Return 5Y48.89%

Ownership

Insiders Held1.16%
Institutions Held128.08%
Institutions Float Held129.58%
Institutional HolderSharesReport Date
Blackrock Inc.5,134,0272026-03-31
Janus Henderson Group PLC1,825,6512026-03-31
Invesco Ltd.1,591,9092026-03-31
Fuller & Thaler Asset Management Inc.1,499,5842026-03-31
Renaissance Technologies, LLC1,469,4492026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
LTGOLatigo Biotherapeutics Inc. $15.60 +5.48% -10.60 $938.39M 0.00%
PCRXPacira BioSciences, Inc. $36.32 -0.21% 71.14 $1.43B 0.00%
SCLXScilex Holding Company $3.08 +3.96% -0.05 $26.13M 0.00%

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. is led by CEO Vikram Karnani, employs 357 people, headquartered in US, publicly traded since 2015.

Collegium Pharmaceutical, Inc. (COLL) stock trades at $22.30 with a market capitalization of $723.27M. The stock is valued at a price-to-earnings (P/E) ratio of 14.47, price-to-book of 2.30, price-to-sales of 0.89. Over the past 52 weeks the stock has ranged between $21.58 and $50.79, and currently trades 56.1% below its 52-week high.

On profitability, Collegium Pharmaceutical, Inc. generates a return on equity (ROE) of 15.96%, above the typical market average, return on capital employed of 10.25%, an operating margin of 15.96%, a net profit margin of 5.93%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1178.66 +0.77% JNJ Johnson & Johnson $260.92 +1.73% ABBV AbbVie Inc. $277.08 +1.71% MRK Merck & Company, Inc. Common Stock (new) $146.45 +2.86% UNH UnitedHealth Group Incorporated Common Stock (DE) $377.83 +1.86% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $660.73 +1.34% AMGN Amgen Inc. $417.21 +2.40% GILD Gilead Sciences, Inc. $151.27 +2.83% ABT Abbott Laboratories $99.17 +0.69% NVO Novo Nordisk A/S $38.42 +0.62%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides